Haemonetics (HAE) Tops Q2 EPS by 2c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.88 +0.44%
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $242 million versus the consensus estimate of $233.45 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Credo Technology shares rise on analyst support and conference comments
- Citi upgrades Haemonetics to Buy, raises price target to $123
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
